Janet Gunzburg Sells 912 Shares of Phreesia, Inc. (NYSE:PHR) Stock

Phreesia, Inc. (NYSE:PHRGet Free Report) insider Janet Gunzburg sold 912 shares of the firm’s stock in a transaction on Thursday, April 18th. The stock was sold at an average price of $22.85, for a total value of $20,839.20. Following the completion of the sale, the insider now directly owns 35,220 shares of the company’s stock, valued at approximately $804,777. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website.

Janet Gunzburg also recently made the following trade(s):

  • On Wednesday, April 10th, Janet Gunzburg sold 2,768 shares of Phreesia stock. The shares were sold at an average price of $23.10, for a total value of $63,940.80.
  • On Monday, April 8th, Janet Gunzburg sold 1,709 shares of Phreesia stock. The shares were sold at an average price of $22.62, for a total value of $38,657.58.
  • On Tuesday, March 19th, Janet Gunzburg sold 2,817 shares of Phreesia stock. The shares were sold at an average price of $23.27, for a total value of $65,551.59.
  • On Friday, February 9th, Janet Gunzburg sold 480 shares of Phreesia stock. The shares were sold at an average price of $28.00, for a total value of $13,440.00.
  • On Thursday, February 1st, Janet Gunzburg sold 328 shares of Phreesia stock. The shares were sold at an average price of $25.99, for a total value of $8,524.72.

Phreesia Trading Down 4.1 %

Phreesia stock opened at $21.70 on Monday. Phreesia, Inc. has a 52 week low of $12.05 and a 52 week high of $34.98. The company has a debt-to-equity ratio of 0.02, a quick ratio of 1.78 and a current ratio of 1.78. The firm has a market capitalization of $1.22 billion, a PE ratio of -8.61 and a beta of 0.92. The business’s 50-day simple moving average is $24.28 and its 200-day simple moving average is $21.33.

Phreesia (NYSE:PHRGet Free Report) last issued its quarterly earnings results on Thursday, March 14th. The company reported ($0.56) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.58) by $0.02. Phreesia had a negative return on equity of 53.33% and a negative net margin of 38.42%. The firm had revenue of $95.00 million for the quarter, compared to analyst estimates of $93.52 million. During the same period in the previous year, the company posted ($0.72) earnings per share. The company’s quarterly revenue was up 24.0% compared to the same quarter last year. Equities research analysts forecast that Phreesia, Inc. will post -1.48 earnings per share for the current year.

Analyst Ratings Changes

PHR has been the subject of a number of research reports. Truist Financial initiated coverage on Phreesia in a research report on Monday, February 26th. They set a “buy” rating and a $35.00 price objective for the company. Raymond James reaffirmed an “outperform” rating and issued a $30.00 price target (up previously from $25.00) on shares of Phreesia in a research report on Friday, March 15th. JMP Securities boosted their price target on Phreesia from $28.00 to $30.00 and gave the stock a “market outperform” rating in a research report on Thursday, March 21st. Stephens reaffirmed an “overweight” rating and issued a $28.00 price target on shares of Phreesia in a research report on Friday, March 22nd. Finally, Needham & Company LLC reaffirmed a “buy” rating and issued a $29.00 price target on shares of Phreesia in a research report on Friday, March 15th. Two research analysts have rated the stock with a hold rating and twelve have given a buy rating to the company. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $31.62.

Check Out Our Latest Stock Report on PHR

Hedge Funds Weigh In On Phreesia

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. CI Investments Inc. increased its stake in Phreesia by 6.6% during the third quarter. CI Investments Inc. now owns 477,265 shares of the company’s stock valued at $8,915,000 after acquiring an additional 29,500 shares during the period. Schroder Investment Management Group acquired a new stake in Phreesia during the third quarter valued at approximately $6,514,000. TimesSquare Capital Management LLC boosted its holdings in Phreesia by 7.8% during the third quarter. TimesSquare Capital Management LLC now owns 774,079 shares of the company’s stock valued at $14,460,000 after purchasing an additional 55,793 shares in the last quarter. Trust Point Inc. acquired a new stake in Phreesia during the fourth quarter valued at approximately $239,000. Finally, Lazard Asset Management LLC boosted its holdings in Phreesia by 58.6% during the third quarter. Lazard Asset Management LLC now owns 424,047 shares of the company’s stock valued at $7,921,000 after purchasing an additional 156,711 shares in the last quarter. 92.10% of the stock is currently owned by institutional investors.

About Phreesia

(Get Free Report)

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.

See Also

Insider Buying and Selling by Quarter for Phreesia (NYSE:PHR)

Receive News & Ratings for Phreesia Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phreesia and related companies with MarketBeat.com's FREE daily email newsletter.